Armata Pharmaceuticals, Inc. |
Director, 10%+ Owner |
Common Stock |
16.4M |
$81.8M |
$5.00 |
Mar 31, 2022 |
Indirect |
Entasis Therapeutics Holdings Inc. |
10%+ Owner |
Common Stock |
29.3M |
$64.4M |
$2.20 |
Jul 11, 2022 |
Indirect |
Armata Pharmaceuticals, Inc. |
Director, 10%+ Owner |
Common Stock |
8.71M |
$43.6M |
$5.00 |
Mar 31, 2022 |
Direct |
Armata Pharmaceuticals, Inc. |
Director, 10%+ Owner |
Warrants to Purchase Common Stock |
8.71M |
$43.6M |
$5.00 |
Mar 31, 2022 |
Direct |
Entasis Therapeutics Holdings Inc. |
10%+ Owner |
Common Stock |
18.7M |
$41.1M |
$2.20 |
Jul 8, 2022 |
Direct |
Entasis Therapeutics Holdings Inc. |
10%+ Owner |
Warrants to Purchase Common Stock |
18.7M |
$37.3M |
$2.00 |
Jul 8, 2022 |
Direct |
Entasis Therapeutics Holdings Inc. |
10%+ Owner |
Warrants to Purchase Common Stock |
10M |
$20M |
$2.00 |
Jul 8, 2022 |
Indirect |
Armata Pharmaceuticals, Inc. |
Director, 10%+ Owner |
Warrants to Purchase Common Stock |
2.69M |
$13.5M |
$5.00 |
Mar 31, 2022 |
Indirect |
Entasis Therapeutics Holdings Inc. |
10%+ Owner |
Convertible Promissory Note |
0 |
|
|
Jul 8, 2022 |
Indirect |
Armata Pharmaceuticals, Inc. |
Director, 10%+ Owner |
Convertible Debt convertible into Common Stock |
$30M |
|
|
Jan 10, 2023 |
Indirect |